Hair Growth Effect of Emulsion Extracted Brevilin A, a JAK3 Inhibitor, from Centipeda minima

被引:13
作者
Ha Kim, Byoung [1 ]
Lee, Won-Yung [2 ]
Trinh, Tuy An [2 ]
Pyo, Jae Sung [3 ]
Lee, Sooyeun [4 ]
Kim, Chang-Eop [2 ]
Lee, Dong Hwan [5 ]
Park, Eun-Seok [6 ]
Kang, Ki Sung [2 ]
机构
[1] D Nat Co Ltd, Seongnam 13174, South Korea
[2] Gachon Univ, Coll Korean Med, Seongnam 13120, South Korea
[3] Kyungsung Univ, Coll Pharm, Busan 48434, South Korea
[4] Keimyung Univ, Coll Pharm, 1095 Dalgubeoldaero, Daegu 42601, South Korea
[5] GFC Life Sci Co Ltd, Korea Dermatol Res Inst, Seongnam 13517, South Korea
[6] Sungkyunkwan Univ, Sch Pharm, Suwon 16419, South Korea
基金
新加坡国家研究基金会;
关键词
hair growth; brevilin A; Centipeda minima; Janus kinase-signal transducer and activator of transcription signaling pathway; network pharmacology; ALOPECIA-AREATA; CONSTITUENTS; GENE; KEGG;
D O I
10.3390/pr8070767
中图分类号
TQ [化学工业];
学科分类号
0817 ;
摘要
Janus kinase 3 (JAK3) inhibitors have been used effectively in the treatment of several cases of alopecia universalis and its variants. Our study aims to evaluate whether the emulsion extract of brevilin A fromCentipeda minima(CMX) stimulates hair regrowth in a clinical trial, as a JAK3 inhibitor, combined with network pharmacology-based analysis. CMX showed potent inhibition of JAK3 in a concentration-dependent manner. Significant differences in total hair count, terminal hair count, and anagen hair count from the baseline to 24 weeks were observed between the placebo and CMX subjects. The gene set enrichment analysis showed that the targets of CMX are mainly associated with the JAK-STAT signaling pathway, cytokine-cytokine receptor interactions, and the MAPK signaling pathway. This study suggests that the medicinal herbal extract CMX is useful in the treatment of mild to moderate vertex balding that contribute to the visible improvements in hair growth observed in treated patients.
引用
收藏
页数:14
相关论文
共 33 条
[1]   Qualitative and quantitative analysis of sesquiterpene lactones in Centipeda minima by UPLC-Orbitrap-MS & UPLC-QQQ-MS [J].
Chan, Chi-on ;
Xie, Xiu-juan ;
Wan, Siu-wai ;
Zhou, Gao-li ;
Yuen, Ailsa Chui-ying ;
Mok, Daniel Kam-wah ;
Chen, Si-bao .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2019, 174 :360-366
[2]   Qualitative and quantitative analysis of chemical constituents of Centipeda minima by HPLC-QTOF-MS & HPLC-DAD [J].
Chan, Chi-on ;
Jin, Deng-ping ;
Dong, Nai-ping ;
Chen, Si-bao ;
Mok, Daniel Kam Wah .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2016, 125 :400-407
[3]   Brevilin A, a Novel Natural Product, Inhibits Janus Kinase Activity and Blocks STAT3 Signaling in Cancer Cells [J].
Chen, Xing ;
Du, Yuping ;
Nan, Jing ;
Zhang, Xinxin ;
Qin, Xiaodong ;
Wang, Yuxin ;
Hou, Jianwen ;
Wang, Qin ;
Yang, Jinbo .
PLOS ONE, 2013, 8 (05)
[4]  
COURTOIS M, 1994, SKIN PHARMACOL, V7, P84
[5]   The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature [J].
Crowley, Erika L. ;
Fine, Shamone C. ;
Katipunan, Kathleen Kwan ;
Gooderham, Melinda J. .
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2019, 23 (03) :289-297
[6]   The role of Janus kinase inhibitors in the treatment of alopecia areata: A systematic review [J].
de Oliveira, Ana B. ;
Alpalhao, Miguel ;
Filipe, Paulo ;
Maia-Silva, Joao .
DERMATOLOGIC THERAPY, 2019, 32 (05)
[7]   Inhibiting Janus kinases to treat alopecia areata [J].
Divito, Sherrie J. ;
Kupper, Thomas S. .
NATURE MEDICINE, 2014, 20 (09) :989-990
[8]   Alopecia areata: A tissue specific autoimmune disease of the hair follicle [J].
Gilhar, A ;
Kalish, RS .
AUTOIMMUNITY REVIEWS, 2006, 5 (01) :64-69
[9]   Medical Progress Alopecia Areata [J].
Gilhar, Amos ;
Etzioni, Amos ;
Paus, Ralf .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (16) :1515-1525
[10]  
Hordinsky Maria K, 2013, J Investig Dermatol Symp Proc, V16, pS13, DOI 10.1038/jidsymp.2013.4